Latanostad Comp (Latanoprost, Timolol)

• Latanostad Comp, a prostaglandin analog and beta‑blocker eye drop, is indicated for conditions that require reduction of intra‑ocular pressure.
• Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage.
• Ocular hypertension: lowers eye pressure to reduce risk of developing glaucoma.
• Secondary open‑angle glaucoma: assists in controlling pressure when caused by other ocular conditions.
• Pseudoexfoliation glaucoma: helps manage elevated pressure.

• Latanoprost/timolol combines two mechanisms. Latanoprost, a prostaglandin F‑type receptor agonist, remodels the extracellular matrix of the ciliary muscle, enhancing uveoscleral outflow of aqueous humor. Timolol, a non‑selective β‑adrenergic antagonist, blocks β1 and β2 receptors in the ciliary body, decreasing aqueous humor production. This dual action provides a more consistent pressure control compared with monotherapy.

Latanostad Comp may cause ocular and systemic adverse reactions; they are categorized by frequency and severity.

Common Side Effects

• Eye irritation or burning sensation
• Blurred vision shortly after instillation
• Redness of the conjunctiva
• Increased eyelash growth
• Darkening of the iris color

Serious or Rare Side Effects

• Severe allergic reaction (e.g., angioedema)
• Ocular inflammation or uveitis
• Marked reduction in heart rate (bradycardia)
• Bronchospasm in susceptible individuals
• Systemic hypotension leading to dizziness

Before prescribing Latanostad Comp, clinicians should consider several precautionary measures to ensure patient safety.

• Monitor intra‑ocular pressure: assess baseline and follow‑up measurements after initiation.
• Assess cardiovascular status: timolol may cause bradycardia or affect blood pressure.
• Avoid in patients with asthma or COPD: beta‑blockade can precipitate bronchospasm.
• Use caution in severe ocular surface disease: may exacerbate irritation.
• Pregnancy and lactation: safety not established; weigh potential risks against benefits.
• Store at room temperature: keep in original container, protect from light and moisture.

Latanostad Comp can interact with other medications, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• Non‑selective beta‑blocker antagonists (e.g., propranolol): additive bradycardia.
• Systemic beta‑agonists (e.g., albuterol): reduced bronchodilator effect.
• Other prostaglandin analog eye drops: increased risk of ocular side effects.

Moderate Interactions (Monitor Closely)

• Carbonic anhydrase inhibitor eye drops: additive intra‑ocular pressure lowering effect.
• Alpha‑agonist ocular drops (e.g., apraclonidine): possible additive hypotensive effect.
• Systemic antihypertensives: monitor blood pressure for excessive lowering.